Position in DXCM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,262,656
-$4,287,416 QoQ
Shares Held
20,106
-68.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Atom Investors LP holds $10,546,211 across 9 Medical Devices names. DXCM ranks #4 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
9,224 | $3,030,914 | |
| 2 | ABT |
Abbott Laboratories
|
20,909 | $2,146,727 | |
| 3 | STE |
STERIS plc
|
9,605 | $2,123,953 | |
| 4 | DXCM |
Dexcom Inc
This page
|
20,106 | $1,262,656 | |
| 5 | CERS |
Cerus Corp
|
351,214 | $639,209 | |
| 6 | PRCT |
PROCEPT BioRobotics Corp
|
15,807 | $395,333 | |
| 7 | SNN |
Smith & Nephew PLC
|
12,339 | $392,133 | |
| 8 | NEOG |
Neogen Corp
|
34,329 | $318,916 |
All Filings in DXCM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,262,656 | 20,106 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $5,550,072 | 63,582 | Shares | Sole | 2025-08-14 | |
| 2024-06-30 | $1,149,446 | 10,138 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $948,291 | 6,837 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $574,784 | 4,632 | Shares | Sole | 2024-02-14 | |
| 2020-09-30 | $276,812 | 2,686 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||